Eledon Pharmaceuticals (ELDN) Other Non-Current Assets (2013 - 2026)

Eledon Pharmaceuticals has reported Other Non-Current Assets for 14 years, with the latest figure at $32.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 9048.59% year-over-year to $32.4 million; the trailing twelve-month figure through Mar 2026 stood at $32.4 million (up 9048.59% YoY), and the FY2025 full-year result was $322000.0, down 11.29% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $32.4 million, up from $322000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $32.4 million in Q1 2022, with the low at $210000.0 in Q3 2024.
• Historically, Other Non-Current Assets has averaged $21.1 million across 5 years, with a median of $32.4 million in 2022.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 99.35% — and 2025, when it surged 15321.9%.
• Eledon Pharmaceuticals' Other Non-Current Assets stood at $32.4 million in 2022, then changed by 0.0% to $32.4 million in 2023, then slumped by 98.88% to $363000.0 in 2024, then slipped by 11.29% to $322000.0 in 2025, then surged by 9957.76% to $32.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $32.4 million (Q1 2026), $322000.0 (Q4 2025), and $32.4 million (Q3 2025), per Business Quant data.